Investorideas.com, an investor research portal specializing in investing ideas in leading sectors including biotech and medical technology stocks, issues an exclusive Q&A with Jim Joyce, Chairman and CEO of Aethlon Medical, Inc. (OTCQB: AEMD). Mr. Joyce discusses the recent launch of its new Exosome Sciences, Inc. (ESI) and what that potentially represents to Aethlon and its shareholders.
Seven out of 9 hospitals and healthcare providers surveyed "strongly" agreed that medical device makers need to step up their cybersecurity and privacy practices, according to a study conducted by the Deloitte Center for Health Solutions.
In the field of medical technology, wireless devices are seeing some of the most broad-reaching growth. This is due mostly in part to the wide range of applications that wireless medicine encompasses. Mobi Health News reports that the top ten areas wireless medicine has directly benefited include: Alzheimer’s, asthma, breast cancer, COPD, depression, diabetes, heart failure, hypertension, obesity, and sleep disorders.
I can be a kid at heart. And when I say that, I state it with an almost literal meaning. I still enjoy toys. Now, I’m not the 40-year-old virgin character from the movie of the same name, but I can’t admit to not still tinkering with Lego bricks and finding enjoyment from it.
American Academy of Family Physicians Scientific Assembly—Innovative solutions that help improve patient outcomes and practice workflow will be on display at the American Academy of Family Physicians (AAFP) Scientific Assembly this week in San Diego.
Given Imaging has announced that Japan's Pharmaceuticals and Medical Devices Agency has granted approval for the PillCam SB 3 system. The innovative technology in this third-generation system will provide physicians throughout Japan with the most advanced PillCam capsule endoscopy technology to detect and monitor small bowel diseases, such as Crohn's disease.
The medical device and diagnostics market is set to grow at 4.5 percent per year (CAGR) between 2012 and 2018, totalling $455 billion in 2018, according to the newly-released EvaluateMedTech World Preview 2013, Outlook to 2018: The Future of Medtech report from market intelligence firm Evaluate Ltd.
Mayo Clinic researchers have shown that a specific protein pair may be a successful prognostic biomarker for identifying smoking-related lung cancers. The protein — ASCL1 — is associated with increased expression of the RET oncogene, a particular cancer-causing gene called RET.
Researchers at MIT have developed a microfluidic device that mimics the flow of cancer cells through a system of blood vessels. Using high-resolution time-lapse imaging, the researchers captured the moments as a cancer cell squeezes its way through a blood vessel wall into the surrounding extracellular matrix.
A new, non-invasive imaging technique, magnetic resonance elastography, can now help physicians accurately detect fibrosis in children with chronic liver disease. A new study shows that MRE detects such chronic diseases as non-alcoholic fatty liver disease, which is increasingly common in children and teens, affecting an estimated 13 percent of adolescents.
Florida Hospital Collaborates with VTT of Finland to Explore Research for Early Detection of Alzheimer’s DiseaseSeptember 19, 2013 11:36 am | by Technical Research Centre of Finland (VTT) | News | Comments
In an effort to better understand the development of Alzheimer’s disease, Florida Hospital Neuroscience Institute and VTT Technical Research Centre of Finland are collaborating to identify the biomarker assay that may predict early onsets of the disease.
It happens too often: A doctor isn't sure what's causing someone's feverish illness but prescribes antibiotics just in case, drugs that don't work if a virus is the real culprit. Now Duke University researchers are developing a blood test to more easily tell when a respiratory illness is due to a virus and not a bacterial infection, hoping to cut the dangerous overuse of antibiotics and speed the right diagnosis.
A handheld device for diagnosing the early signs of osteoporosis could be available for clinical use within five years. The technology is currently being refined and tested at the University of Southampton with support from the Engineering and Physical Sciences Research Council (EPSRC).
Imec and Panasonic are jointly developing a fully integrated sample-to-answer device to perform molecular diagnostic tests. Recently, they’ve created prototype of the device. The chip is about half the size of a credit card that performs fast, simple and sensitive detection of genetic markers, specifically single nucleotide polymorphisms (SNPs).
Scientists seeking new ways to fight cancer often try to understand the subtle, often invisible, changes to DNA, proteins, cells, and tissue that alter the body's normal biology and cause disease. Now, to aid in that fight, a team of researchers has developed a sophisticated new optical imaging tool that enables scientists to look deep within tumors and uncover their inner workings.
Life sciences is one industry that is currently undergoing a turbulent development environment. Major advancements such as next-generation DNA sequencing and molecular imaging are expected to drive growth in categories such as immunochemistry and genetic testing. Add to this that changes in government regulations and market conditions are forcing life science OEMs to build their products using faster, smaller more modular technologies.
With funding from the National Institute for Health Research, experts at The University of Nottingham have developed a highly accurate prototype technique which can produce a detailed ‘spectroscopic fingerprint’ of each tissue layer removed during surgery.
Routine screening has been touted as the most effective way to stem cancer deaths, but it may instead put patients in harm's way, according to American Cancer Society chief medical officer Dr. Otis Brawley. Speaking at a seminar last week, Brawley warned that hospitals recommending regular screening may be looking out for their profits rather than their patients.
Logical Images, the Rochester-based company that created the nation's only widely used diagnostic decision tool, VisualDx, announced today that it has been awarded a U.S. patent for its unique visual diagnostic process and system that, in addition to other features, selectively presents and displays images based upon descriptive characteristics of a patient.
A protein called isocitrate dehydrogenase (IDH1) is present at high levels in lung cancers and can be detected in the blood, making it a noninvasive diagnostic marker for lung cancers, according to a study published in Clinical Cancer Research, a journal of the American Association for Cancer Research.
Aydogan Ozcan, a professor of electrical engineering and bioengineering at the UCLA Henry Samueli School of Engineering and Applied Science, and his team have created a portable smartphone attachment that can be used to perform sophisticated field testing to detect viruses and bacteria without the need for bulky and expensive microscopes and lab equipment.
Flexpoint Sensor Systems, Inc. today announced they expect to complete both Phase Two and Phase Three of development of the colonoscope application during the remainder of 2013. The company will receive milestone cash payments for each stage of the development process.
Fraunhofer FIT demonstrates a mobile wireless system that monitors the health of elderly people in their own homes, using miniature sensors, and also a novel optical system for detecting antibiotic resistance, which can determine in just two hours if bacteria react to a specific antibiotic.
The National Institutes of Health has awarded Georgia Tech a $2-million research grant to unravel the mechanical forces at play in lymphedema, a poorly understood disease with no cure and little hope for sufferers. Lymphedema develops when the body fails to circulate lymphatic fluid, a mixture of immune cells, proteins, and lipids.
Andrew Fish, executive director of AdvaMedDx, a division of the Advanced Medical Technology Association (AdvaMed) focused on diagnostics policy matters, released the following statement on the introduction in the U.S. House of Representatives of the Modernizing Our Drug and Diagnostics Evaluation and Regulatory Network (MODDERN) Cures Act.